Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated April 4th, 2021

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
"The Bachelor's" Tia Booth Reveals Dad's Stage 4 Colon Cancer Diagnosis; What To Know About This Disease
NOW
PLAYING
Irish Singer Linda Nolan Battling Breast Cancer Alongside Her Sister
NOW
PLAYING
'Country Ever After' Star Coffey Anderson Puts on Concert To Support Wife Criscilla Battling Stage 4 Colon Cancer
NOW
PLAYING
A New Option for Some People With Lung Cancer: How This Immunotherapy/Chemotherapy Combo Can Increase Treatment Success
NOW
PLAYING
Exploring the Treatment Options for Metastatic Bladder Cancer

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.